These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10356751)

  • 41. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of the reactogenicity and immunogenic potency of combined vaccine "Bubo-Kok" in the immunization of children against diphtheria, tetanus, pertussis and viral hepatitis B].
    Fel'dblium IV; Nikolaeva AM; Kuz'ianin AV; Borisova VN; Mel'nikov VA; Chuprinina RP; Perelygina OV; Shalunova NV; Semenova VD; Griaznova DV; Pushkareva EV; Uvitskiĭ AIu; Alekseeva IA; Konopleva OA; Budanov MV; Iakovleva IM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):58-62. PubMed ID: 15554315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mechanisms of formation of post-vaccinal immune response in children immunized with APDT and ADT-M preparations].
    Kharseeva GG; Savis'ko AA; Kostinov MP; Labushkina AV; Ivanova IA; Telesmanich NR; Trukhachev AL
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (2):72-8. PubMed ID: 25051700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemic diphtheria in the Newly Independent States of the former USSR--situation and lessons learned.
    Dittmann S
    Biologicals; 1997 Jun; 25(2):179-86. PubMed ID: 9236049
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials.
    Van Damme P; McIntyre P; Grimprel E; Kuriyakose S; Jacquet JM; Hardt K; Messier M; Van Der Meeren O
    Vaccine; 2011 Aug; 29(35):5932-9. PubMed ID: 21718738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Halperin SA; Langley JM; Ye L; MacKinnon-Cameron D; Elsherif M; Allen VM; Smith B; Halperin BA; McNeil SA; Vanderkooi OG; Dwinnell S; Wilson RD; Tapiero B; Boucher M; Le Saux N; Gruslin A; Vaudry W; Chandra S; Dobson S; Money D
    Clin Infect Dis; 2018 Sep; 67(7):1063-1071. PubMed ID: 30010773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
    Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemic diphtheria in the Kyrgyz Republic, 1994-1998.
    Glinyenko VM; Abdikarimov ST; Firsova SN; Sagamonjan EA; Kadirova R; Nuorti JP; Strebel PM
    J Infect Dis; 2000 Feb; 181 Suppl 1():S98-S103. PubMed ID: 10657199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of meningococcal conjugate vaccines with other conjugate or diphtheria-tetanus containing vaccines.
    Badahdah AM; Tashani M; Khatami A; Booy R; Rashid H
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30376098
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.
    Collins CL; Salt P; McCarthy N; Chantler T; Lane L; Hemme F; Diggle L; Buttery J; Kitchin NR; Moxon ER; Pollard AJ
    Vaccine; 2004 Oct; 22(31-32):4262-9. PubMed ID: 15474717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The antidiphtheria and antitetanus immunities of children of the Maritime Territory after the use of adsorbed DTP vaccine and adsorbed DT-m anatoxin].
    Zaporzhets TS; Lunika IG; Greben'kova LK; Belogolovkina NA; Makarenkova ID; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):57-9. PubMed ID: 10356739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diphtheria prevention among children in Denmark].
    Hansen KG; Rønne T
    Nord Med; 1995; 110(2):48-9, 52. PubMed ID: 7854910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.
    Martins Rde M; Camacho LA; Marcovistz R; Noronha TG; Maia Mde L; dos Santos EM; Barbosa GG; Silva AM; Souza PC; Lemos MC; Homma A
    Mem Inst Oswaldo Cruz; 2008 Nov; 103(7):711-8. PubMed ID: 19057823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [THE EPIDEMIOLOGICAL EFFICACY OF PERTUSSIS-DIPHTHERIA-TETANUS VACCINATION].
    GORDINA RV; ZAKHAROVA MS; OSTROUKHOVA DI; KURAGINA RV; KORASHEVICH VP
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Dec; 40():9-13. PubMed ID: 14154144
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
    Avendano A; Ferreccio C; Lagos R; Horwitz I; Cayazzo M; Fritzell B; Meschievitz C; Levine M
    Pediatr Infect Dis J; 1993 Aug; 12(8):638-43. PubMed ID: 8414775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.